Concrete Infra & Media Ltd.

BSE

Price on BSE 02 Jun,16:01 LIVE

4.17

+0.05

(+1.21%)

Volume :
3,589.00

Prev Close :
4.12

Day's H/L (Rs.) :
4.17 - 4.04

52wk H/L (Rs.) :
3.99 - 2.76

Mkt Cap (Rs. Cr) :
2.98

NSE

Concrete Infra & Media Ltd. is not listed on NSE

Report Card - Concrete Infra & Media Ltd.

PE Ratios

6.43

EPS (Rs.)

0.65

Sales (Rs. Cr)

1.31

Face Value (Rs.)

Net Profit Margin(%)

0.62

Last Bonus

Last Dividend(%)

Return on Average Equity

5.81

News for Concrete Infra & Media Ltd.

Stock Markets Fall: IT Stocks Drag Indices Down

Sensex and Nifty decline in early trade due to IT stock selling, foreign fund outflows, and West Asia instability fears.

Apr 22, 2026 10:00

iD Fresh Aims for Rs 2,500 Cr Revenue in 4 Years

iD Fresh Food targets Rs 2,500 crore revenue in 4 years, driven by expansion, innovation, and rising demand for fresh food.

Apr 14, 2026 18:56

Bhutan Punatsangchhu-I Hydropower Project Resumes

Work restarts on Bhutan's Punatsangchhu-I hydropower project after 7-year halt. India-funded project aims completion in 5 years.

Apr 11, 2026 16:48

UP Realty Hit by LPG Shortage: Credai Seeks Intervention

LPG shortage and black marketing disrupt construction in Western UP. Credai urges CM intervention to protect projects and workers.

Apr 10, 2026 21:05

CII Delegation in China: Economic Partnership Focus

CII delegation engages Chinese businesses in Shanghai, exploring deeper economic partnership after ties normalisation.

Apr 10, 2026 17:25

More News for Concrete Infra & Media Ltd. »

News for Finance

India Real Estate: Capital Inflows Rise 72% to $5.1 Billion

Indian real estate sees record $5.1 billion capital inflow in Jan-Mar, a 72% rise. Developers & REITs drive growth despite global uncertainty.

Apr 22, 2026 11:03

Ajanta Pharma Gets USFDA Form 483 with 5 Observations

USFDA issues Form 483 with five observations to Ajanta Pharma's Paithan facility in Maharashtra after inspection. Company to respond soon.

Apr 22, 2026 10:59

Lupin Launches Anti-Diabetic Tablets in US

Lupin launches generic dapagliflozin and metformin hydrochloride extended-release tablets in the US after USFDA approval.

Apr 22, 2026 10:51

HCLTech Shares Tank After Earnings

HCLTech shares fell nearly 10% after March quarter earnings. FY27 growth guidance is 1-4%. AI revenue crosses $620M.

Apr 22, 2026 10:48

RBI Monitors FDI Outflows, Exchange Rates

RBI Governor Sanjay Malhotra closely monitors short-term fluctuations like FDI outflows and exchange rate movements. India's strong macroeconomic fundamentals highlighted.

Apr 22, 2026 10:48

More News »

Top News

India Real Estate: Capital Inflows Rise 72% to $5.1 Billion

Indian real estate sees record $5.1 billion capital inflow in Jan-Mar, a 72% rise. Developers & REITs drive growth despite global uncertainty.

Apr 22, 2026 11:03

Ajanta Pharma Gets USFDA Form 483 with 5 Observations

USFDA issues Form 483 with five observations to Ajanta Pharma's Paithan facility in Maharashtra after inspection. Company to respond soon.

Apr 22, 2026 10:59

Lupin Launches Anti-Diabetic Tablets in US

Lupin launches generic dapagliflozin and metformin hydrochloride extended-release tablets in the US after USFDA approval.

Apr 22, 2026 10:51

HCLTech Shares Tank After Earnings

HCLTech shares fell nearly 10% after March quarter earnings. FY27 growth guidance is 1-4%. AI revenue crosses $620M.

Apr 22, 2026 10:48

RBI Monitors FDI Outflows, Exchange Rates

RBI Governor Sanjay Malhotra closely monitors short-term fluctuations like FDI outflows and exchange rate movements. India's strong macroeconomic fundamentals highlighted.

Apr 22, 2026 10:48

More Top News »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist